Category

Podcast Highlights

Insights On the Pediatric, Adolescent & Adult AD Patient

By Atopic Dermatitis, Podcast Highlights No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Insights On the Pediatric, Adolescent & Adult AD Patient

Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman

 

You can’t truly understand someone until you walk a mile in their shoes. This is true to so many aspects of daily life, especially when it comes to chronic, relapsing, relentless medical issues. Enter the poster child: Atopic Dermatitis (AD). This exceedingly common chronic inflammatory disease is unavoidable in practice, and to best manage/partner with the millions of patients out there, it is on us to view/appreciate this condition beyond the practitioner lens.

In this 3rd episode of a 5 part podcast series, host Dr. Adam Friedman is joined by Dr. Lindsey Finklea, a practicing dermatologist and parent/caregiver of a child with severe AD, and Dr. Peter Lio, podcast veteran and AD focused Derm extraordinaire, to discuss the issues affecting patient-family/patient-caregiver interactions and offer clinical pearls for effective management strategies to best assist the needs of parents, families and caregivers for patients with the AD.

Listen Now
This podcast is supported by an independent medical education grant provided by Sanofi Genzyme Regeneron.
Learning Objectives
Upon completion of this podcast, learners should be able to:
  • Cite the unique clinical implications of atopic dermatitis specific to the pediatric, adolescent and adult AD patient; and
  • Recognize the impact of AD on the patient-family and patient-caregiver dynamic

Disclosures

Adam Friedman, MD, FAAD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speakers’ Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.
Peter Lio, MD – Advisory Board: Altus Labs, Arbonne, Bodewell, Dermavant Sciences, DermTap, Inc., DermVeda, gpower, inc., IntraDerm Pharmaceuticals, Johnson & Johnson Consumer Products Company, Menlo Therapeutics, Micreos Human Health B.V., Modernizing Medicine, National Eczema Association, Realm Therapeutics, Regeneron, Sanofi US Services, Syncere Skin Systems, UCB, Verrica Pharmaceuticals Inc, YobeeCare Inc. Board of Directors: National Eczema Association. Consultant: AbbVie, Amyris, Inc., Burt’s Bees, Dermira, Eli Lilly and Company, Exeltis, Franklin BioScience, Kiniksa Pharmaceuticals, Ltd., L’Oreal USA Inc., LEO Laboratories Ltd (LEO Pharma), Odeza LLC, Theraplex, TopMD, Unilever. Investigator: AbbVie, AOBiome, LLC, La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis, National Eczema Association, Regeneron. Speaker: Galderma USA, La Roche-Posay Laboratorie Pharmaceutique, Pfizer Inc., Pierre Fabre Dermatologie, Regeneron. Stockholder: LearnHealth/LearnSkin, Medable, Modernizing Medicine. Royalties: Theraplex.
Lindsay Finklea, MD – No relevant disclosures.

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

New Developments in Tetracycline-Class Antibiotics

By Podcast Highlights No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

New Developments in Tetracycline-class Antibiotics

Dr. Christopher Bunick & Dr. Adam Friedman

 

Tetracycline antibiotics are like the Snickers of dermatology. Instead of “Hungry? Grab a Snickers,” “Acne? Grab a tetracycline…” for months even though this goes against clinical guidelines and concerns regarding antimicrobial resistance (woof, thats a mouthful for a slogan). Like a Snickers, they fulfill a need, they’re good for a whole lot, but too much, not so good. We have seen some evolution in maximizing the clinical benefits of our therapeutic Snickers, such as subantimicrobial dosing, but more innovation is needed to get the most anti-inflammatory bang for our buck. Enter the concept of narrow spectrum antibiotics and sarecycline.

 Join host Dr. Adam Friedman on an investigative journey detailing how antibiotic structure and function can meet to yield novel properties with Dr. Chris Bunick, Associate Professor of Dermatology at Yale School of Medicine and captain of crystallography and cryo-electron microscopy. Hear first hand how a simple idea morphed into a groundbreaking program. Complete your understanding of how antibiotics can be anti-inflammatory. Love the new narrow spectrum lexicon (or try at least).

Listen Now
This enduring activity is supported by an independent medical education grant provided by Almirall, LLC.
Learning Objectives
Upon completion of this podcast, learners should be able to:
  • Summarize the mechanism of action of tetracycline antibiotics and their role in acne
  • Define narrow spectrum antibiotic, and understand the clinical translation.

Disclosures

 

Adam Friedman, MD, FAAD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speakers’ Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.
Christopher Bunick, MD, PhD – Grant/Research: Almirall, Consultant: Almirall, Speakers’ Bureau: Almirall

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

By Podcast Highlights No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

Dr. Peter Lio and Dr. Adam Friedman

 

In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam Friedman is joined by the dynamic dermatitis duo Dr. Anna De Benedetto, Associate Professor of Dermatology at the University of Florida, and Dr. Eric Simpson, Professor of Dermatology at the School of Medicine at Oregon Health & Science University, to dissect established and emerging pathophysiologic details of this dastardly dermatitis.

Dig in to determine best evidence based management practices to dampen the long standing burden of disease. Discover delightful discourse between three dedicated AD investigators/caregivers. Do listen, don’t scratch.

Listen Now
This podcast is supported by an independent medical education grant provided by Sanofi Genzyme Regeneron.

 

Learning Objectives:
Upon completion of this podcast, learners should be able to:
  • Summarize recent scientific understanding of the pathophysiology, etiology and prevalence of atopic dermatitis in patients of all age groups
  • Recognize the implications of long-term treatment options on effective patient outcomes.

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Treating the AD Patient During COVID-19

By Podcast Highlights No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Treating the AD Patient During COVID-19

Dr. Peter Lio and Dr. Adam Friedman

 

Atopic dermatitis is a relentless, recurring, unreasonable, often recalcitrant inflammatory skin disease that impacts millions of children and adults in the United States alone and requires a tailored treatment plan and ongoing follow up. Now add a global pandemic to the mix – awesome.

Join podcast host Dr Adam Friedman and atopic dermatitis antagonist Dr. Peter Lio as they discuss practical approaches to managing atopic dermatitis in the era of COVID-19. Telemedicine, topicals, and tons of systemic talk!

Listen Now
This podcast is supported by an independent medical education grant provided by Sanofi Genzyme Regeneron.

 

Learning Objectives:
Upon completion of this podcast, learners should be able to:
  • Formulate AD treatment plans that may decrease susceptibility and spread of viral infections, including COVID-19
  • Identify new and emerging therapeutic considerations for managing atopic dermatitis during the current COVID-19 pandemic

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Understanding and Changing Patient Behavior and Minimizing Risk of UV Damage

By Podcast Highlights, Skin Cancer No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Understanding and Changing Patient Behavior and Minimizing Risk of UV Damage

Drs. Sherry Pagoto and Adam Friedman

 

Why is is that we tend to do things we know are bad for us? Candy, alcohol, Tinder…the list goes on. What about not following practices that have a library of evidence supporting their use, like sunscreen and photo-protection?

To better understand this conundrum JDD Podcast host Dr. Adam Friedman recruited mental health guru Dr. Sherry Pagoto, Professor in the Department of Allied Health Sciences at the University of Connecticut and Director of the UConn Center for mHealth and Social Media, to dive deep into human behavior and how this relates to medical compliance.
Find a couch to lie down on as you digest the litany of psychosocial pearls Dr. Pagoto shares, rounded out by some evidenced based guidance on using social media to engage a broader audience. #dontmissthispodcast
This podcast was supported by Johnson & Johnson Consumer Inc.
Listen Now
CME Available
This enduring continuing education activity is supported by an independent medical education grant provided by Johnson & Johnson Consumer Inc. Participants who earn a minimum, passing grade of 70% would be eligible to receive up to 0.5 credit hours AMA PRA Category 1™ and ANCC credit per podcast. A total of 1 hour for this two-part Sun Protection series.

Learning Objectives

 

Upon completion of this enduring, internet-based series of continuing education activities,  participants should be able to:
  • Develop strategies leading to effective clinician-patient dialogues to better motivate patients to integrate regular use of sunscreens in their skin care regimen
Take CME Now

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

NEW from the JDD Podcast: “The Science of Sun Protection”

By Photoprotection, Podcast Highlights, Skin Cancer No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

The Science of Sun Protection
Part I

Dr. Neal Bhatia and Dr. Adam Friedman

 

Photoprotection works, plain and simple. Yet all too often we must defend good science, dispel unfounded myths, and offer our first born children to get our patients to utilize sunscreen the right way when this behavior directly and primarily benefits them. Why is this and how do we airdrop knowledge in a meaningful way?
In part one of this bonus two part podcast series dedicated to the science and psychology of sunscreen use, AAD Vice President Elect Neal Bhatia, MD joins host Adam Friedman, MD to slather on some practical approaches to communicating sunscreen science and real world use.
Listen Now
CME Credits Available
This enduring continuing education activity is supported by an independent medical education grant provided by Johnson & Johnson Consumer Inc. 
Participants who earn a minimum, passing grade of 70% would be eligible to receive up to 0.5 credit hours AMA PRA Category 1™ and ANCC credit per podcast. A total of 1 hour for this two-part Sun Protection series.
Learning Objectives:
Upon completion of this enduring, internet-based series of continuing education activities,  participants should be able to:
  • Differentiate features, benefits and limits of chemical and physical sunblocking products
  • Discuss the role of product formulation, delivery vehicle and patient type when recommending sun protection strategies
  • Review multifunctional approaches to photoprotection including use of sunscreen-containing moisturizers and other skin care products
  • Develop strategies leading to effective clinician-patient dialogues to better motivate patients to integrate regular use of sunscreens in their skin care regimen
Take CME Now

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Support the (On)cause: A Practical Review of Supportive Oncodermatology

By Podcast Highlights, Skin Cancer No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Support the (On)cause: A Practical Review of Supportive Oncodermatology

Drs. Mario Lacouture and Adam Friedman

 

Cancer sucks, plain and simple. What is often overlooked is that the life saving/altering therapies often come with substantial baggage adding to this proclamation with skin, hair, and nail adverse events significantly impacting quality of life and even treatment course.
Enter supportive oncodermatology, and along with it the mastermind behind this rapidly emerging field, Dr. Mario Lacouture, Professor and Director of the Oncodermatology Program in the Dermatology Service, Department of Medicine, at Memorial Sloan Kettering Cancer Center in New York City.
Dr. Lacatoure joins podcast host Dr. Adam Friedman to discuss the array of cutaneous clusters that not only can, but are almost expected to occur during cancer therapy. Learn how even simple OTC products can contribute to both ameliorating and even preventing some of these sequelae. Understand how you (yeah, I’m talkin’ to you) can make an extraordinary impact in these patients’ lives. Tune in to this podcast to support your supportive oncoderm fund of knowledge.
This podcast was supported by Johnson & Johnson Consumer Inc.
Listen Now
Upcoming Related Supplement:
  • The Biological Impact of Oats: Eczema and Beyond
  • Blair Allais MD and Adam Friedman MD FAAD
  • Department of Dermatology, George Washington School of Medicine and Health Sciences, Washington, DC
  • October 2020 | Volume 19 | Issue 10 | Supplement| Copyright © October 2020

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Systemic Antibiotics in the Management of Acne: Issues and Considerations for Optimal Care

By Acne, Podcast Highlights No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

"Systemic Antibiotics in the Management of Acne: Issues and Considerations for Optimal Care"

Drs. Joslyn Kirby and Adam Friedman

 

WEEEEEEERE BACK! Join host Dr. Adam Friedman for lively and learned discussion with Dr. Joslyn Kirby on one of the most common, chronic, soul-crushing complaints… Acne Vulgaris. It is, from a pathophysiological standpoint, a biological sh*t show, but you need to understand it to develop the best treatment plans. We talk inflammation, first line approaches, setting patient expectations and compliance. We dive deep into the differences between broad-spectrum and narrow-spectrum antibiotics, when to use them, and for how long. (Spoiler alert: NOT TOO LONG!). In our efforts to be stewards of meaningful antibiotic use and adversaries of antimicrobial resistance, narrow-spectrum antibiotics are the future!

This enduring activity is supported by an independent medical education grant provided by Almirall, LLC.

Upon completion of this enduring, internet-based educational activity, participants should be able to:

  • Review current scientific understanding of pathophysiology of acne
  • Summarize acne treatment strategies utilizing systemic antibiotics
  • Differentiate safety and efficacy of broad and narrow spectrum antibiotics indicated for acne treatment
  • Cite the benefits of narrow spectrum antibiotic use in acne therapy
Listen Now
Disclosures:
  • Adam Friedman, MD, FAAD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speaker’s Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.
  • Joslyn R. Sciacca Kirby, MD – No relevant disclosures.

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Best Practices & Practical Pearls For Safely Reopening Derm Practices

By Podcast Highlights, Safely Reopening Derm Practices Video Series No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

This video series and podcast are supported in part by Alastin Skincare, Endo Aesthetics, Ortho Dermatologics, and Sciton

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Drs. Adam Friedman, Jeffery Dover, Nazanin Saedi, Kavita Mariwalla, Terrence Keaney & Thomas E. Rohrer

 

The COVID-19 pandemic has affected dermatology practices across the country and around the world. In the face of a change that no one was really prepared for, Dr. Jeffrey S. Dover, in partnership with the JDD, invited a panel of dermatology Key Opinion Leaders to share their experience via video as they reopen their practices. We have gathered the audio from all of these videos and assembled them into an easy to listen to podcast filled with practical pearls and best practices from Drs. Jeffrey Dover, Nazanin Saedi, Kavita Mariwalla, Terrence Keaney, and Thomas Rohrer.

Want a refresher on the use of OCPs in Acne? Interested in learning how to initiate a patient based survey study? Just curious how a leader in the field gets an uninterested adolescent to be compliant and engaged in his/her acne care? These are just a few of the practical pearls provided.

Listen Now
Watch the companion videos here:
Read Article Now

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Acne, OCPs, and a Side Order of Practical Pearls for the Adolescent Patient

By Acne, Podcast Highlights No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

"Acne, OCPs, and a Side Order of Practical Pearls for the Adolescent Patient"

Dr. Adam Friedman and Dr. Lawrence Eichenfield

JDD Podcast host Dr. Adam Friedman gets first-hand insight from internationally acclaimed pediatric dermatologist Dr. Lawrence Eichenfield on his recent study entitled “Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients” published in the June 2016 edition of the Journal of Drugs of Dermatology.

Want a refresher on the use of OCPs in Acne? Interested in learning how to initiate a patient based survey study? Just curious how a leader in the field gets an uninterested adolescent to be compliant and engaged in his/her acne care? These are just a few of the practical pearls provided.

Listen Now
Article Cited in this Post
Read Article Now

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Hispanic Tattoo Artists Could Provide Skin Cancer Prevention via Aftercare Instructions and Social Media

By Podcast Highlights, Skin of Color No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

"Hispanic Tattoo Artists Could Provide Skin Cancer Prevention via Aftercare Instructions and Social Media."

featuring Dr. Adam Friedman, Dr. Robert P. Dellavalle, Dr. Cristian D. Gonzalez

Continued efforts by the dermatology community to educate the public on both photoprotective measures and early skin cancer detection through surveillance has made a significant impact but the battle is far from over, especially in diverse skin phototypes for whom myths and misinformation are still pervasive regarding this space.

Innovative strategies are still sorely needed! Enter mentor-mentee duo Robert P. Dellavalle MD PhD MSPH from the University of Colorado School of Medicine and Cristian D. Gonzalez MD from University of Texas Southwestern, who are no doubt going to create some buzz with their December 2019 JDD study “Hispanic Tattoo Artists Could Provide Skin Cancer Prevention via Aftercare Instructions and Social Media.”

Tune in to hear how both doctors and artists can become allies in canvas (aka skin) cancer education dissemination. Learn how social media can be used as an effective research tool to both recruit and collect data. By the time you are through with this custom work, you will be loyal to the coil.

Listen Now
CME Available

Upon completion of this enduring activity, participants should be able to

  • discuss gaps in Hispanic tattoo artists’ understanding of skin cancer and willingness to disseminate sun protection information
  • identify opportunities to improve sun safety practices in at risk populations
  • and utilize social media as an emerging population health research tool.
Haven’t listened to this podcast? Listen to it here.
Take CME Now

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Podcast | No Comments
You can't truly understand someone until you walk a mile in their shoes. This is true to so many aspects of daily life, especially when it comes to chronic, relapsing,…

New Developments in Tetracycline-class Antibiotics

| Podcast | No Comments
Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a tetracycline..." for months even though this goes against clinical guidelines and concerns regarding…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast | No Comments
In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam Friedman is joined by the dynamic dermatitis duo Dr. Anna De Benedetto, Associate Professor…

Capturing Consensus and Cutting Out Misconceptions Regarding the Aesthetic Skin of Color Consumer

By Podcast Highlights, Skin of Color No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

"Capturing Consensus and Cutting Out Misconceptions Regarding the Aesthetic Skin of Color Consumer"

featuring Dr. Adam Friedman & Dr. Andrew Alexis
Who knows what’s best/worst for facial aesthetics in the skin of color patient? No really who? Because there is a great deal of folklore and ballyhoo related to what one can and cannot do, forgetting even what the patients think.
Enter Dr. Andrew Alexis, Professor and Chair of the Department of Dermatology at Mount Sinai St. Luke’s and Mount Sinai West and Director of the Skin of Color Center, with his experienced SOC entourage to marry personal experience and evidence (what a beautiful couple!).

Tune in to hear how it all went down. You couldn’t be in the room where it happened, but after this podcast you might have well been. Learn from one of the greats as I pick his brain on all things, medical and aesthetic, SOC. C to it you don’t miss this podcast.

Listen Now
CME Available
Upon completion of this enduring activity, participants should be able to:
  • Discuss common myths and mis-perceptions with respect to aesthetics and skin of color patients
  • Review unique considerations in order to optimize the management of skin disease in diverse skin types
Take CME Now

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…